arrow_back Back to App

Mandatory Checking of Controlled Substance History Before Prescribing.

This law mandates that doctors in states receiving federal funding must consult state Prescription Drug Monitoring Programs (PDMPs) before prescribing Schedule II, III, or IV controlled substances. The goal is to combat drug misuse and "doctor shopping" by ensuring practitioners have a complete history of a patient's controlled substance prescriptions. Pharmacies must also report dispensing these drugs electronically within 24 hours.
Key points
Practitioners must check the patient's prescription history in the state PDMP before starting treatment with controlled substances and every three months thereafter.
Pharmacies must electronically report the dispensing of controlled substances to the PDMP within 24 hours, ensuring data is nearly real-time.
States must ensure their PDMP data is interoperable and shared with other states to prevent cross-state drug abuse.
State agencies will analyze PDMP data and provide access to law enforcement and medical licensing boards if prescribing patterns appear inconsistent with best practices.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_5563
Sponsor: Sen. Klobuchar, Amy [D-MN]
Process start date: 2024-12-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Prescription Drug Monitoring Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_5563.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-12-17.

What are the main provisions?

Key points include:

  • Practitioners must check the patient's prescription history in the state PDMP before starting treatment with controlled substances and every three months thereafter.
  • Pharmacies must electronically report the dispensing of controlled substances to the PDMP within 24 hours, ensuring data is nearly real-time.
  • States must ensure their PDMP data is interoperable and shared with other states to prevent cross-state drug abuse.
  • State agencies will analyze PDMP data and provide access to law enforcement and medical licensing boards if prescribing patterns appear inconsistent with best practices.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Klobuchar, Amy [D-MN].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health